# Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer

> **NCT00331786** · PHASE1 · COMPLETED · sponsor: **Stony Brook University** · enrollment: 240 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** nitric oxide-releasing acetylsalicylic acid derivative
- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** biopsy

## Key facts

- **NCT ID:** NCT00331786
- **Lead sponsor:** Stony Brook University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2009-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00331786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00331786, "Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00331786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*